BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Herrmann M, Kindermann I, Müller S, Georg T, Kindermann M, Böhm M, Herrmann W. Relationship of Plasma Homocysteine with the Severity of Chronic Heart Failure. Clinical Chemistry 2005;51:1512-5. [DOI: 10.1373/clinchem.2005.049841] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Taban-shomal O, Kilter H, Wagner A, Schorr H, Umanskaya N, Hübner U, Böhm M, Herrmann W, Herrmann M. The Cardiac Effects of Prolonged Vitamin B12 and Folate Deficiency in Rats. Cardiovasc Toxicol 2009;9:95-102. [DOI: 10.1007/s12012-009-9038-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
2 Herrmann M, Müller S, Kindermann I, Günther L, König J, Böhm M, Herrmann W. Plasma B vitamins and their relation to the severity of chronic heart failure. The American Journal of Clinical Nutrition 2007;85:117-23. [DOI: 10.1093/ajcn/85.1.117] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
3 Azzini E, Ruggeri S, Polito A. Homocysteine: Its Possible Emerging Role in At-Risk Population Groups. Int J Mol Sci 2020;21:E1421. [PMID: 32093165 DOI: 10.3390/ijms21041421] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 11.5] [Reference Citation Analysis]
4 Herrmann W, Herrmann M, Joseph J, Tyagi SC. Homocysteine, brain natriuretic peptide and chronic heart failure: a critical review. Clinical Chemical Laboratory Medicine 2007;45. [DOI: 10.1515/cclm.2007.360] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
5 Osorio A, Ortega E, Ruiz-requena E. Two models of homocysteine behavior in acute myocardial infarction. Clinical Biochemistry 2008;41:277-81. [DOI: 10.1016/j.clinbiochem.2007.05.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
6 Azizi-Namini P, Ahmed M, Yan AT, Keith M. The role of B vitamins in the management of heart failure. Nutr Clin Pract 2012;27:363-74. [PMID: 22516940 DOI: 10.1177/0884533612444539] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
7 Guéant-rodriguez R, Juillière Y, Nippert M, Abdelmouttaleb I, Herbeth B, Aliot E, Danchin N, Guéant J. Left ventricular systolic dysfunction is an independent predictor of homocysteine in angiographically documented patients with or without coronary artery lesions. Journal of Thrombosis and Haemostasis 2007;5:1209-16. [DOI: 10.1111/j.1538-7836.2007.02535.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
8 Lee JH, Jarreau T, Prasad A, Lavie C, O'Keefe J, Ventura H. Nutritional assessment in heart failure patients. Congest Heart Fail 2011;17:199-203. [PMID: 21790970 DOI: 10.1111/j.1751-7133.2011.00239.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
9 Strauss E, Supinski W, Radziemski A, Oszkinis G, Pawlak AL, Gluszek J. Is hyperhomocysteinemia a causal factor for heart failure? The impact of the functional variants of MTHFR and PON1 on ischemic and non-ischemic etiology. Int J Cardiol 2017;228:37-44. [PMID: 27863359 DOI: 10.1016/j.ijcard.2016.11.213] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
10 Moshal KS, Tipparaju SM, Vacek TP, Kumar M, Singh M, Frank IE, Patibandla PK, Tyagi N, Rai J, Metreveli N, Rodriguez WE, Tseng MT, Tyagi SC. Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia. Am J Physiol Heart Circ Physiol 2008;295:H890-7. [PMID: 18567713 DOI: 10.1152/ajpheart.00099.2008] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 5.0] [Reference Citation Analysis]
11 Naruszewicz M, Jankowska EA, Zymlinski R, Bukowska H, Millo B, Banasiak W, Ponikowski P. Hyperhomocysteinemia in patients with symptomatic chronic heart failure: Prevalence and prognostic importance—pilot study. Atherosclerosis 2007;194:408-14. [DOI: 10.1016/j.atherosclerosis.2006.08.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
12 Jin N, Huang L, Hong J, Zhao X, Chen Y, Hu J, Cong X, Xie Y, Pu J. Elevated homocysteine levels in patients with heart failure: A systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e26875. [PMID: 34414939 DOI: 10.1097/MD.0000000000026875] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Topçuoğlu C, Yılmaz FM, Şahin D, Aydoğdu S, Yılmaz G, Saydam G, Yücel D. Total-and lipid-associated sialic acid in serum and thrombocytes in patients with chronic heart failure. Clinical Biochemistry 2010;43:447-9. [DOI: 10.1016/j.clinbiochem.2009.11.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
14 Moshal KS, Kumar M, Tyagi N, Mishra PK, Metreveli N, Rodriguez WE, Tyagi SC. Restoration of contractility in hyperhomocysteinemia by cardiac-specific deletion of NMDA-R1. Am J Physiol Heart Circ Physiol 2009;296:H887-92. [PMID: 19181966 DOI: 10.1152/ajpheart.00750.2008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
15 Pasaoglu OT, Turkozkan N, Ark M, Polat B, Agilli M, Yaman H. The Effect of Taurine on the Relationship Between NO, ADMA and Homocysteine in Endotoxin-Mediated Inflammation in HUVEC Cultures. Inflammation 2014;37:1439-43. [DOI: 10.1007/s10753-014-9868-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
16 Herrmann M, Taban-shomal O, Hübner U, Böhm M, Herrmann W. A review of homocysteine and heart failure. European Journal of Heart Failure 2006;8:571-6. [DOI: 10.1016/j.ejheart.2005.11.016] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
17 Rohilla A, Singh G, Singh M, Bala kumar P. Possible involvement of PKC-δ in the abrogated cardioprotective potential of ischemic preconditioning in hyperhomocysteinemic rat hearts. Biomedicine & Pharmacotherapy 2010;64:195-202. [DOI: 10.1016/j.biopha.2009.04.030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
18 Herrmann M, Taban-shoma O, Hübner U, Pexa A, Kilter H, Umanskaya N, Hans Straub R, Böhm M, Herrmann W. Hyperhomocysteinemia and Myocardial Expression of Brain Natriuretic Peptide in Rats. Clinical Chemistry 2007;53:773-80. [DOI: 10.1373/clinchem.2006.077859] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
19 Herrmann M, Stanger O, Paulweber B, Hufnagl C, Herrmann W. Effect of folate supplementation on N-terminal pro-brain natriuretic peptide. Int J Cardiol 2007;118:267-9. [PMID: 17052779 DOI: 10.1016/j.ijcard.2006.07.034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
20 Görmüş U, Ozmen D, Ozmen B, Parildar Z, Ozdoğan O, Mutaf I, Bayindir O. Serum N-terminal-pro-brain natriuretic peptide (NT-pro-BNP) and homocysteine levels in type 2 diabetic patients with asymptomatic left ventricular diastolic dysfunction. Diabetes Res Clin Pract 2010;87:51-6. [PMID: 19932518 DOI: 10.1016/j.diabres.2009.10.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
21 Cho SE, Hong KS, Shin GJ, Chung WS. The methylenetetrahydrofolate reductase C677T gene mutation is associated with hyperhomocysteinemia, cardiovascular disease and plasma B-type natriuretic peptide levels in Korea. Clin Chem Lab Med. 2006;44:1070-1075. [PMID: 16958597 DOI: 10.1515/cclm.2006.194] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
22 Sundström J, Vasan RS. Homocysteine and heart failure: a review of investigations from the Framingham Heart Study. Clin Chem Lab Med 2005;43:987-92. [PMID: 16197286 DOI: 10.1515/CCLM.2005.173] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
23 El-Amrousy D, Hassan S, Hodeib H. Prognostic value of homocysteine and highly sensitive cardiac troponin T in children with acute heart failure. J Saudi Heart Assoc 2018;30:198-204. [PMID: 29983495 DOI: 10.1016/j.jsha.2017.11.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]